{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "19041950", "DateCompleted": {"Year": "2009", "Month": "04", "Day": "30"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1016/j.pupt.2008.11.002"], "ArticleDate": [{"Year": "2008", "Month": "11", "Day": "14"}], "Journal": {"ISSN": "1094-5539", "JournalIssue": {"Volume": "22", "Issue": "1", "PubDate": {"Year": "2009", "Month": "Feb"}}, "Title": "Pulmonary pharmacology & therapeutics", "ISOAbbreviation": "Pulm Pharmacol Ther"}, "ArticleTitle": "Role of cathepsin S in ozone-induced airway hyperresponsiveness and inflammation.", "Pagination": {"StartPage": "27", "EndPage": "32", "MedlinePgn": "27-32"}, "Abstract": {"AbstractText": ["Ambient ozone has been linked to the worsening of symptoms of patients with obstructive diseases such as chronic obstructive pulmonary disease (COPD) and asthma. We investigated the role of cathepsin S on ozone-induced airway hyperresponsiveness (AHR) and inflammation, using the selective cathepsin S inhibitor, Compound A. Balb/c mice were exposed to ozone at a concentration of 3 ppm or air for 3 h, following administration by gavage of Compound A or vehicle. Bronchoalveolar lavage (BAL) was performed 3 h and 20-24 h following exposure, AHR was measured at 20-24 h only. Ozone exposure, compared to air exposure increased BAL cathepsin S levels, AHR and BAL inflammatory cells. Compound A (30 mg kg(-1) p.o.) dosing compared to vehicle dosing inhibited ozone-induced AHR (-logPC100 vehicle: -0.70+/-0.12, n=8 vs. cathepsin S inhibitor: -1.30+/-0.06, P<0.001, n=8) at 20-24 h and BAL neutrophilia at 3 h and 20-24 h (P<0.05, n=6). Ozone exposure increased levels of BAL cytokines IL-6, TNF-alpha and IFN-gamma. Compound A reduced IL-6 at 3 h and 20-24 h (P<0.05, n=5) and TNF-alpha, at 20-24 h (P<0.05, n=6). These data indicate an important role for cathepsin S in the regulation of ozone-induced AHR and neutrophil cell recruitment and suggest that cathepsin S may be a target in the treatment of oxidative stress-induced AHR and inflammation."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Experimental Studies Unit, Airway Disease Section, National Heart and Lung Institute, Imperial College London, Dovehouse St., SW3 6LY London, UK."}], "Identifier": [], "LastName": "Williams", "ForeName": "Alison S", "Initials": "AS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Eynott", "ForeName": "Paul R", "Initials": "PR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Leung", "ForeName": "Sum-Yee", "Initials": "SY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nath", "ForeName": "Puneeta", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jupp", "ForeName": "Ray", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "De Sanctis", "ForeName": "George T", "Initials": "GT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Resnick", "ForeName": "Robert", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Adcock", "ForeName": "Ian M", "Initials": "IM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chung", "ForeName": "Kian Fan", "Initials": "KF"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pulm Pharmacol Ther", "NlmUniqueID": "9715279", "ISSNLinking": "1094-5539"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "82115-62-6", "NameOfSubstance": "Interferon-gamma"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Cathepsins"}, {"RegistryNumber": "EC 3.4.22.27", "NameOfSubstance": "cathepsin S"}], "MeshHeadingList": [{"QualifierName": ["toxicity"], "DescriptorName": "Air Pollutants"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemically induced", "physiopathology"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": [], "DescriptorName": "Bronchoalveolar Lavage"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Cathepsins"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": ["chemically induced", "physiopathology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Interferon-gamma"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-6"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["drug effects"], "DescriptorName": "Neutrophil Infiltration"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "7", "Day": "11"}, {"Year": "2008", "Month": "10", "Day": "28"}, {"Year": "2008", "Month": "11", "Day": "4"}, {"Year": "2008", "Month": "12", "Day": "2", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "5", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "12", "Day": "2", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19041950", "10.1016/j.pupt.2008.11.002", "S1094-5539(08)00109-0"]}}], "PubmedBookArticle": []}